2023 Vaccines Market Report: Market Size, Growth Drivers, and Key Trends

As per The Business Research Company's Vaccines Opportunities And Strategies Market Report 2023, the vaccines market reached a value of nearly $92,607.6 million in 2021, having grown at a compound annual growth rate (CAGR) of 8.1% since 2016. The market is expected to grow from $92,607.6 million in 2021 to $150,931.3 million in 2026 at a rate of 10.3%. The market is then expected to grow at a CAGR of 9.0% from 2026 and reach $232,624.0 million in 2031.      

Rise in cases of invasive cervical cancer is expected to propel the growth of the vaccines market during the forecast period. By using the HPV (Human papillomavirus) vaccine and regular cervical screenings, cervical cancer can be prevented. 

View Complete Report @
https://www.thebusinessresearchcompany.com/report/vaccines-market

Synthetic biology is being increasingly used by companies that are developing vaccines. Synthetic biology is a field of biology which involves engineering principles, whereby molecules and organisms are redesigned for useful purposes by engineering them to have new abilities. Synthetic biology tools significantly aid in drug discovery processes to help understand the molecular mechanisms of target diseases. Traditionally, vaccines are developed using the whole organism. Synthetic vaccines are based on complex carbohydrate-protein conjugates and can be easily stored at normal temperature without the need for refrigeration. Synthetic biology technologies such as DNA (Deoxyribonucleic acid) - and mRNA(Messenger Ribonucleic acid)-based vaccine technologies allow researchers to move rapidly from an organisms genomic sequence to a vaccine that directly encodes the organisms proteins, which can begin clinical trials

The top opportunities in the vaccines market segmented by type will arise in the anti-infective vaccines segment, which will gain $49,866.9 million of global annual sales by 2026. The top opportunities in segment by technology will arise in the conjugate vaccines segment, which will gain $26,610.1 million of global annual sales by 2026. The top opportunities in segment by route of administration will arise in the intramuscular (IM) segment, which will gain $30,201.7 million of global annual sales by 2026. The top opportunities in segment by valence will arise in the multivalent segment, which will gain $38,172.2 million of global annual sales by 2026. The top opportunities in segment by distribution channel will arise in the hospital pharmacies segment, which will gain $37,872.6 million of global annual sales by 2026. The vaccines market size will gain the most in the USA at $27,549.2 million.    

Vaccines Market Segmentation:
The vaccines market is segmented by type, by technology, by route of administration, by valance, by distribution channel.
By Type -
a) Anti-Infective Vaccines
b) Anti-Cancer Vaccines
c) Other Types

By Technology-
a) Conjugate Vaccines
b) Inactivated And Subunit Vaccines
c) Live Attenuated Vaccines
d) Recombinant Vaccines
e) Toxoid Vaccines
f) Other Technologies

By Route Of Administration-
a) Intramuscular (IM)
b) Subcutaneous (SC)
c) Oral
d) Other Route of Administration

By Valance-
a) Monovalent
b) Multivalent
d) Other Route of Administration

By Distribution Channel -
a) Hospital Pharmacies
b) Retail Pharmacies
c) Institutional Sales

Major players in the vaccines market include Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Sanofi S.A., AstraZeneca.

The regions covered in the global vaccines market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Download FREE SAMPLE Report - https://www.thebusinessresearchcompany.com/sample_request?id=5367&type=smp

The latest report from The Business Research Company, 'Global Vaccines Opportunities And Strategies Market Report - Forecast To 2032,' provides a comprehensive global perspective with data and statistics from 60+ geographies, analyzing 7000+ market segments. The regional and country breakdowns section offers insights into each geography's market analysis, size, historic and forecast growth, and key strategies for industry competitiveness.

Vaccines Market Report Table Of Content
1.Executive Summary
2.Table Of Contents
3.List Of Figures
4.List Of Tables
5.Report Structure
6.Introduction And Market Characteristics
……
20. Pipeline Analysis
21. Key Mergers And Acquisitions
22. Global Vaccines Market Opportunities And Strategies
23. Vaccines Market, Conclusions And Recommendations
24.Appendix

PURCHASE the report @
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5367

Get to know us better:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.